Mirati Therapeutics, Inc.

Ensign Peak Advisors, Inc

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/13/2023

Shares

71,355

Value ($000)

3,108

Weight

0.0%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/13/2023	3,108	0.0%	71,355	9/30/2023
2023 Q2	8/14/2023	692	0.0%	19,140	6/30/2023
2023 Q1	5/15/2023	595	0.0%	15,990	3/31/2023
2022 Q4	2/13/2023	725	0.0%	15,990	12/31/2022
2022 Q3	11/14/2022	6,468	0.0%	92,617	9/30/2022
2022 Q2	8/12/2022	6,218	0.0%	92,617	6/30/2022
2022 Q1	5/16/2022	7,615	0.0%	92,617	3/31/2022
2021 Q4	2/11/2022	13,479	0.0%	91,890	12/31/2021
2021 Q3	11/12/2021	13,747	0.0%	77,707	9/30/2021
2021 Q2	8/13/2021	7,894	0.0%	48,872	6/30/2021
2021 Q1	5/12/2021	4,579	0.0%	26,737	3/31/2021
2020 Q4	2/12/2021	4,410	0.0%	20,074	12/31/2020
2020 Q3	11/12/2020	5,167	0.0%	31,108	9/30/2020
2020 Q2	8/12/2020	2,710	0.0%	23,734	6/30/2020
2020 Q1	5/11/2020	2,040	0.0%	26,532	3/31/2020
2019 Q4	2/14/2020	373	0.0%	2,900	12/31/2019